These patients showed a trend toward better PPS when treated with subsequent liver-directed or systemic treatment compared with BSC only (13 vs 5 months).
← all excerpts
Reason of Discontinuation After Transarterial Chemoembolization Influences Survival in Patients with Hepatocellular Carcinoma.
1
—
—